Article
The Frequency and Clinical Implications of the BRAFV600EMutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades
1 Jan 2014
Abstract excerpt
BACKGROUND: Over the past several decades, there has been a rapid worldwide increase in the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the clinicopathological characteristics of this disease. BRAF(V600E), which is a mutation of the proto-oncogene BRAF, has become the most frequent genetic mutation associated with PTC, particularly in Korea. Thus, the present study investigated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
